Corporate Profile

ABOUT US

About Vicplas International Ltd.

Vicplas International Ltd. is a holding company headquartered in Singapore and listed on the SGX mainboard. We operate globally via two wholly-owned subsidiaries: Forefront Medical, which specialises in the research, development and manufacture of medical devices, and Vicplas Pipes, which produces heavy-metal-free plastics solutions and uPVC pipe systems for a variety of applications.

Our Vision

Our Vision

Become a leading global manufacturing partner delivering innovative and sustainable solutions to our customers and partners.

Our Mission

Our Mission

Our mission is to multiply profitability through continuous technological innovation and product and service improvements. This will help us to fulfil our commitment to provide optimum value for our customers, business partners and shareholders.

Our Values

Our Values

  • Quality Performance We build a trusted quality culture
  • Integrity We do what is right
  • Innovation We innovate and drive continuous improvement
  • Customer Focus We deliver attractive solutions to develop successful customers
  • Accountability We take personal responsibility

MILESTONES

The Vicplas Journey

  • 1993

    Founded in Singapore.

  • 1999

    Listed on SGX SESDAQ.

  • 2000

    Established Forefront Medical as part of a joint venture.

  • 2008

    Acquired Forefront Medical as a wholly-owned subsidiary.

  • 2009
    • Transferred to the SGX Mainboard.
    • Established Forefront Medical’s first contract manufacturing plant in Xiamen, China.
  • 2012

    Established Forefront Medical’s second contract manufacturing plant in Changzhou, China.

  • 2016
    • Introduced heavy-metal-free plastics products under Vicplas Pipes.
    • Acquired XentiQ and added electro-mechanical capabilities.
  • 2020

    Acquired Arrow Medical, a UK medical manufacturing facility.

  • 2021

    Achieved Vicplas Pipes’ first Green Check Mark from the Singapore Green Building Council.

OUR LEADERSHIP

Board of Directors

Yeo Wico

Yeo Wico

Non-Executive Independent Chairman of the Board

Ng Cher Yan

Ng Cher Yan

Non-Executive Independent Director

Jane Gaines-Cooper

Jane Gaines-Cooper

Non-Executive Director

Ng Beng Tiong

Ng Beng Tiong

Non-Executive Independent Director

Senior Management

Cheng Liang

Cheng Liang

Managing Director of the Pipes Segment

Walter Tarca

Walter Tarca

Group CEO & President of the Medical Devices Segment

Chen Hsheng Zhang Zixian

Cheng Hsheng

Group Operations Director

Gan Ying Hui

Gan Ying Hui

Chief Financial Officer

Toon Chin Liang

Toon Chin Liang

Technical Director of the Medical Devices Segment

Yeo Wico

Yeo Wico

Non-Executive Independent Chairman of the Board

Yeo Wico, aged 54, was appointed as a Non-Executive Director in June 2008. He was re-elected as a Director at the Annual General Meeting (AGM) of the Company held in November 2019. He is Chairman of the Board of Directors and the Nominating Committee and serves as a member of the Audit and Risk, Remuneration and Strategy Committees. Mr. Yeo is currently a partner of Allen & Gledhill LLP, a Singapore law firm. He has been in legal practice in Singapore as an Advocate and Solicitor of the Supreme Court of Singapore since 1992. In addition, Mr.Yeo was admitted as a non-practising solicitor of England and Wales and as an Attorney and Counselor-at-Law in the State of New York. He graduated from the National University of Singapore in 1991 and holds a LLB (Hons) degree. He also serves as a Non-Executive Director of NetLink NBN Management Pte. Ltd. (the trustee-manager of NetLink NBN Trust) and Changi Airports International Pte. Ltd.. He was previously an independent non-executive director of CitySpring Infrastructure Management Pte. Ltd., the then trustee-manager of CitySpring Infrastructure Trust (now known as Keppel Infrastructure Trust) and a non-executive director of SP Services Limited (a wholly-owned subsidiary of Singapore Power Limited).

He is appointed by the Minister-in-Charge of the Monetary Authority of Singapore as a member of the Appeal Advisory Panels constituted under the Business Trusts Act, Financial Advisers Act, Insurance Act, Securities and Futures Act and Trust Companies Act. In addition, he is appointed by the Minister for Finance as a member of the Income Tax Board of Review. He is also a member of the Corporate Law Advisory Panel, which is a standing advisory panel to the Accounting and Corporate Regulatory Authority. He has completed his terms of service as a member of the Accounting Standards Council.

Ng Cher Yan

Ng Cher Yan

Non-Executive Independent Director

Ng Cher Yan, aged 62, was appointed as a Non-Executive Director in May 2010. He was re-elected as a Director at the AGM of the Company held in November 2019. He is Chairman of the Audit and Risk and Remuneration Committees and serves as a member of the Nominating Committee. Mr. Ng is currently practising as a Chartered Accountant. Mr. Ng holds a Bachelor of Accountancy degree from the National University of Singapore, and is a fellow member of the Institute of Singapore Chartered Accountants and also a member of the Institute of Chartered Accountants in Australia. Currently, Mr. Ng serves as Independent Non-Executive Director of several public listed companies, namely MoneyMax Financial Services Ltd, Samko Timber Limited and Serial System Ltd. In the preceding five years, he was also an independent director of Ecowise Holdings Limited, Bull Will Co Ltd and Mermaid Maritime Public Co Ltd. Mr. Ng was awarded the prestigious Pingat Bakti Masyarakat or the Public Service Award in 2007 and was awarded the Bintang Bakti Masyarakat or the Public Service Star Award in 2017 for his various community services.
Jane Gaines-Cooper

Mrs. Jane Rose Philomene Gaines-Cooper

Non-Executive Director

Jane Rose Philomene Gaines-Cooper, aged 62, was appointed as a Non-Executive Director in November 2016. She was re-elected as a Director at the AGM of the Company held in November 2020. She serves as a member of the Remuneration, Nominating and Strategy Committees. Mrs.Gaines-Cooper is currently the President, Director and Group Chairman of Venner Capital S.A. and was previously a Non-Executive Director of LMA International N.V., a public company that was listed on the Singapore Exchange Securities Trading Limited. She holds a Bachelor of Arts (Hons) degree in Economics from Thames Valley University, London.

Ng Beng Tiong

Mr. Ng Beng Tiong

Non-Executive Independent Director

Ng Beng Tiong, aged 57, was appointed as a Non-Executive Director in April 2021. He serves as a member of the Audit and Risk Committee. Mr. Ng is currently the Deputy Group Chief Executive Officer and Group Chief Operating Officer of ARA Asset Management Limited, a leading APAC real assets fund manager with a global reach. He was previously an independent non-executive director of Micro-Mechanics (Holdings) Limited and Sim Siang Choon Limited, and Finance Director and board member of Low Keng Huat (Singapore) Limited. Mr. Ng holds a Master’s of Engineering (Software Engineering) (First Class Honours) from Imperial College, London. He is a CFA charterholder and a member of the Singapore Institute of Directors.

Cheng Liang

Cheng Liang

Group Chief Executive Officer

Cheng Liang, aged 66, was appointed as Acting Group Chief Executive Officer in October2014 and assumed the permanent role as Group Chief Executive Officer in November 2018. He is responsible for the overall management of the Group. He has been the Managing Director of the pipes and pipe fittings segment of the Group since January 2009 where he oversaw all operational aspects of the pipes and pipe fittings segment, including executing business strategies, manufacturing, procurement and sales and distribution. Mr. Cheng is a founding member of the Group and was previously an Executive Director of the Group from 1998 to 2008. His prior experiences include tin smelting in Singapore and South Korea, tin trading and forex trading.
Walter Tarca

Walter Tarca

President of the Medical Devices Segment

Walter Tarca, aged 64, joined the Group in January 2016 as President of the Medical Devices Segment, where he is responsible for overall strategy and carries full P&L responsibility for the segment. Mr. Tarca brings a wealth of healthcare experience to the group, having held senior leadership positions in businesses throughout the APAC region including China, Japan, India and South Korea. Mr. Tarca has lived in Asia for more than 20 years and has a successful track record of building and expanding health care businesses in a sustainable manner, focusing on collaborative customer relationships, operating excellence and an engaged workforce. Mr. Tarca has also held positions in general management, operations and finance in retail operations in Australia and in manufacturing of automotive components and child safety products for a leading global manufacturer. Mr. Tarca has a bachelor’s degree in Economics from Adelaide University and is a Fellow, CPA.
Chen Hsheng Zhang Zixian

Chen Hsheng @ Zhang Zixian

Group Operations Director

Cheng Hsheng @ Zhang Zixian, aged 44, was appointed as Acting Group Operations Director in April 2015 and assumed the permanent role as Group Operations Director in April 2016. He is responsible for the operational aspects of the Group, as well as ensuring operational support for development of the Group’s markets, products and businesses. He has been the Business Operations Director for pipes and pipe fittings segment since August 2012. Mr. Cheng began his career with the pipes and pipe fittings segment in 2001 as an Engineer and has held roles of increasing responsibilities in various functions, such as Production, Operations and Business Development. His other experiences also include the compounding of specialty engineering plastics and elastomers.
Gan Ying Hui

Gan Ying Hui

Chief Financial Officer

Gan Ying Hui, aged 42, rejoined the Group as Chief Financial Officer in April 2016. She joined the Group as Financial Controller in August 2008 and was promoted to CFO in August 2013 before she left in December 2014. Ms. Gan is responsible for the Group’s financial functions including accounting, internal controls and auditing, financial and management reporting, tax, financial analysis, mergers and acquisition support and risk management. Prior to that, she was an audit manager with a “Big Four” Public Accounting firm in Singapore. Ms. Gan holds a Bachelor of Accountancy (Hons) from the Nanyang Technological University and is a Chartered Accountant of Singapore.
Toon Chin Liang

Toon Chin Liang

Technical Director of the Medical Services Segment

Toon Chin Liang, aged 43, joined the medical devices segment of the Group in May 2014 as the Quality, Assurance and Regulatory Affairs Director and subsequently as the Technical Director in May 2015. Prior to joining the Group, he was the Quality Engineering Manager in one of the largest Swiss pharmaceutical and medical devices companies.
vicplas